Delivery Order SPE2DB20D3303-SPE2DB25FA1YZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,368.92 for AYVAKIT 25 mg tablets (30-count packaging) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- The Defense Logistics Agency awarded a $24,368.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count supply) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a pediatric cancer medication delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the supply of the drug AYVAKIT 25 MG TABLET 30S. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a $46,651.36 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of the pharmaceutical product AYVAKIT 25 MG TABLET 30S and has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $21,918 to Amerisourcebergen Drug Corporation to supply 4561812928 AYVAKIT 300 MG tablets. Under the terms of the order, Amerisourcebergen will deliver 30 boxes of the medication to a location in Conshohocken, Pennsylvania, with performance required between August 10 and 31, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order to support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,368.92, is for the delivery of 4568149543 AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has a period of performance through May 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $23,325.68, is for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. This award is a part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. The IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1YZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitive award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary distribution center. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, under which this delivery order was likely issued. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military healthcare supply chain. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill specialized pharmaceutical requirements through competitive procurement, with prior awards spanning diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical supplies. The firm fixed-price structure and competitive award process reflect standard federal procurement practices for pharmaceutical commodities managed through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 7/30/25 |